#Japan #Tokyo #KUROJIKA #Daiken Medical #FOCAL

Nobuo Hayakawa's Appointment as Outside Director

Nobuo Hayakawa, the CEO of KUROJIKA, has been announced as the incoming outside director of Daiken Medical Corporation, effective June 24, 2026, contingent upon approval at the annual shareholders' meeting. This appointment underscores the importance of enhancing corporate governance within Daiken Medical, which has embarked on a transformative new management structure aimed at strengthening its oversight mechanisms by incorporating external perspectives.

Established in Tokyo's Shibuya district, KUROJIKA is known for its development of "FOCAL," an AI solution designed to drive profit generation for the wholesale and manufacturing industries. Hayakawa’s expertise in consulting and technology development has been pivotal for small and medium enterprises, showcasing his commitment to fostering sustainable business practices. His track record in providing consulting services has led to his nomination as an outside director at Daiken Medical, positioning him to contribute valuable insights into the company's governance and strategic direction.

The Path to Appointment

Daiken Medical Corporation, headquartered in Izumi City, Osaka, has recognized the need for external governance to improve its operating frameworks. By appointing Hayakawa, the company aims to benefit from his extensive experience in profit-making strategies that have proven effective in the competitive landscapes of the manufacturing and wholesale sectors.

Hayakawa’s role will be to independently oversee the management functions at Daiken Medical, with a focus on enhancing the company’s long-term value generation. His understanding of the challenges faced by medium-sized enterprises in optimizing their operations will be crucial in advising Daiken Medical's board.

Background of Nobuo Hayakawa

Nobuo Hayakawa founded KUROJIKA in May 2022, after accumulating a wealth of experience across various sectors, including banking at Tokyo Mitsubishi, and corporate roles at Misumi, JINS, and Walmart Japan. His diverse background equips him with a unique perspective on business management and operational efficiencies.

At KUROJIKA, Hayakawa has led initiatives focused on profit generation consulting and the development of the profit-generating AI, FOCAL. Under his leadership, the company has worked tirelessly to empower SMEs through innovative solutions tailored to their operational needs.

Company Profile: KUROJIKA

• - Location: Shibuya, Tokyo, Japan
• - Established: May 2022
• - CEO: Nobuo Hayakawa
• - Business Focus: Profit generation consulting, development and provision of FOCAL AI
• - Website: KUROJIKA | FOCAL

With Hayakawa’s forthcoming role at Daiken Medical, the collaboration is expected to usher in a new era of corporate governance that harmonizes innovation with proven leadership frameworks. As industries continue to evolve, such strategic appointments highlight the importance of diversified expertise in steering companies toward sustainable success.

The future looks promising for both KUROJIKA and Daiken Medical as they embark on this journey together, tapping into Hayakawa’s invaluable insights for their continued growth and innovation in the marketplace.